AAAAAA
Results: 26-50/70
Authors:
SCHMITT M
HARBECK N
THOMSSEN C
WILHELM O
MAGDOLEN V
REUNING U
ULM K
HOFLER H
JANICKE F
GRAEFF H
Citation: M. Schmitt et al., CLINICAL IMPACT OF THE PLASMINOGEN ACTIVATION SYSTEM IN TUMOR INVASION AND METASTASIS - PROGNOSTIC RELEVANCE AND TARGET FOR THERAPY, Thrombosis and haemostasis, 78(1), 1997, pp. 285-296
Authors:
TURKMEN B
SCHMITT M
SCHMALFELDT B
TROMMLER P
HELL W
CREUTZBURG S
GRAEFF H
MAGDOLEN V
Citation: B. Turkmen et al., MUTATIONAL ANALYSIS OF THE GENES ENCODING UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND ITS INHIBITOR PAI-1 IN ADVANCED OVARIAN-CANCER, Electrophoresis, 18(5), 1997, pp. 686-689
Authors:
ZINCKE M
AVRIL N
DOSE J
ROMER W
ZIEGLER S
NATHRATH W
JANICKE F
GRAEFF H
SCHWAIGER M
Citation: M. Zincke et al., PET IMAGING OF BREAST-CANCER - COMPARISION BETWEEN FDG UPTAKE VS HISTOLOGY AND EXPRESSION OF THE GLUCOSE-TRANSPORTER PROTEIN GLUT-1, The Journal of nuclear medicine, 38(5), 1997, pp. 250-250
Authors:
GRAEFF H
WILMANNS W
JANICKE F
SAUER H
CLASSEN S
Citation: H. Graeff et al., PROGNOSTIC AND THERAPEUTIC FACTORS IN BRE AST-CANCER - RESULTS OF A CONSENSUS CONFERENCE, Geburtshilfe und Frauenheilkunde, 57(8), 1997, pp. 143-146
Authors:
DOSE J
AVRIL N
ZIEGLER S
BENSE S
ROMER W
WEBER W
SCHWAIGER M
JANICKE F
GRAEFF H
Citation: J. Dose et al., RANKING OF POSITRON EMISSION TOMOGRAPHY ( PET) WITH F-18 FLUORODEOXYGLUCOSE (FDG) IN THE DIAGNOSIS OF CARCINOMAS OF THE BREAST, Geburtshilfe und Frauenheilkunde, 57(6), 1997, pp. 315-320
Authors:
SCHMITT M
THOMSSEN C
ULM K
SEIDERER A
HARBECK N
HOFLER H
JANICKE F
GRAEFF H
Citation: M. Schmitt et al., TIME-VARYING PROGNOSTIC IMPACT OF TUMOR BIOLOGICAL FACTORS UROKINASE (UPA), PAI-1 AND STEROID-HORMONE RECEPTOR STATUS IN PRIMARY BREAST-CANCER, British Journal of Cancer, 76(3), 1997, pp. 306-311
Authors:
DETTMAR P
HARBECK N
THOMSSEN C
PACHE L
ZIFFER P
FIZI K
JANICKE F
NATHRATH W
SCHMITT M
GRAEFF H
HOFLER H
Citation: P. Dettmar et al., PROGNOSTIC IMPACT OF PROLIFERATION-ASSOCIATED FACTORS MIBI (KI-67) AND S-PHASE IN NODE-NEGATIVE BREAST-CANCER, British Journal of Cancer, 75(10), 1997, pp. 1525-1533
Authors:
LUTHER T
MAGDOLEN V
ALBRECHT S
KASPER M
RIEMER C
KESSLER H
GRAEFF H
MULLER M
SCHMITT M
Citation: T. Luther et al., EPITOPE-MAPPED MONOCLONAL-ANTIBODIES AS TOOLS FOR FUNCTIONAL AND MORPHOLOGICAL ANALYSES OF THE HUMAN UROKINASE RECEPTOR IN TUMOR-TISSUE, The American journal of pathology, 150(4), 1997, pp. 1231-1244
Authors:
KOLBEN M
BLASER J
ULM K
SCHMITT M
SCHNEIDER KTM
TSCHESCHE H
GRAEFF H
Citation: M. Kolben et al., ANGIOGENIN PLASMA-LEVELS DURING PREGNANCY, American journal of obstetrics and gynecology, 176(1), 1997, pp. 37-41
Authors:
AVRIL N
DOSE J
JANICKE F
ZIEGLER S
ROMER W
WEBER W
HERZ M
NATHRATH W
GRAEFF H
SCHWAIGER M
Citation: N. Avril et al., ASSESSMENT OF AXILLARY LYMPH-NODE INVOLVEMENT IN BREAST-CANCER PATIENTS WITH POSITRON EMISSION TOMOGRAPHY USING RADIOLABELED 2-(FLUORINE-18)FLUORO-2-DEOXY-D-GLUCOSE, Journal of the National Cancer Institute, 88(17), 1996, pp. 1204-1209
Authors:
BRUNNER G
FERGUSON MWJ
GRAEFF H
MAGDOLEN V
WILHELM O
Citation: G. Brunner et al., REGULATION OF THE GPI-ANCHORED UROKINASE RECEPTOR BY THE GPI - SPECIFIC PHOSPHOLIPASE-D, Molecular biology of the cell, 7, 1996, pp. 1572-1572
Authors:
KOLBEN M
HOSS C
GRAEFF H
Citation: M. Kolben et al., POSTOPERATIVE THROMBOLYTIC THERAPY, Der Internist, 37(6), 1996, pp. 619-622
Authors:
KUHN W
SCHMALFELDT B
DOSE J
PACHE L
ULM K
FREITAG K
JANICKE F
GRAEFF H
Citation: W. Kuhn et al., ORAL AND PARENTERAL ETOPOSIDE IN PLATINUM REFRACTORY OVARIAN-CANCER PATIENTS - RESULTS OF A PROSPECTIVE RANDOMIZED STUDY, Geburtshilfe und Frauenheilkunde, 56(2), 1996, pp. 105-110
Authors:
MAGDOLEN V
RETTENBERGER P
KOPPITZ M
GORETZKI L
KESSLER H
WEIDLE UH
KONIG B
GRAEFF H
SCHMITT M
WILHELM O
Citation: V. Magdolen et al., SYSTEMATIC MUTATIONAL ANALYSIS OF THE RECEPTOR-BINDING REGION OF THE HUMAN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, European journal of biochemistry, 237(3), 1996, pp. 743-751
Authors:
MAGDOLEN V
SCHMITT M
GRAEFF H
RIEMER C
KESSLER H
ALBRECHT S
MULLER M
LUTHER T
Citation: V. Magdolen et al., EPITOPE-MAPPED MONOCLONAL-ANTIBODIES DIRECTED TO THE HUMAN UROKINASE RECEPTOR (UPAR, CD87), Tissue antigens, 48(4-II), 1996, pp. 202-202
Authors:
THOMSSEN C
SCHMITT M
GORETZKI L
OPPELT P
PACHE L
DETTMAR P
JANICKE F
GRAEFF H
Citation: C. Thomssen et al., PROGNOSTIC VALUE OF THE CYSTEINE PROTEASES CATHESPINS-B AND CATHEPSIN-L IN HUMAN BREAST-CANCER, Clinical cancer research, 1(7), 1995, pp. 741-746
Authors:
HARBECK N
SCHWARZE S
SCHUREN E
YAMAMOTO N
MONIWA N
SCHMITT M
DETTMAR P
NATHRATH W
JANICKE F
HOFLER H
GRAEFF H
Citation: N. Harbeck et al., MODEL SYSTEM FOR ISOLATION OF COMPETENT OVARIAN-CARCINOMA CELLS FROM FRESH TUMOR-TISSUE BY A MAGNETIC SEPARATION TECHNIQUE (MACS), International journal of oncology, 6(6), 1995, pp. 1249-1254
Authors:
GNIRS J
BUNK W
SCHNEIDER KTM
MORFILL GE
GRAEFF H
Citation: J. Gnirs et al., COMPLEXITY ANALYSIS OF FETAL ECG SIGNALS DURING LABOR, Gynakologisch-geburtshilfliche Rundschau, 35, 1995, pp. 36-41
Authors:
KOLBEN M
LOPENS A
BLASER J
HUBER A
FRANK M
WILHELM O
WILHELM S
SCHNEIDER KTM
ULM K
TSCHESCHE H
SCHMITT M
GRAEFF H
Citation: M. Kolben et al., CONCENTRATION OF DIFFERENT PROTEOLYTIC AN D ANGIOGENIC FACTORS IN PLASMA AND PLACENTA EXTRACT OF PATIENTS WITH HELLP-SYNDROME, PRE- ECLAMPSIA, AND HIGHLY PATHOLOGICAL DOPPLER FLOW MEASUREMENTS/, Gynakologisch-geburtshilfliche Rundschau, 35, 1995, pp. 126-131
Authors:
HARBECK N
DETTMAR P
THOMSSEN C
PACHE L
ZIFFER P
FIZI K
JANICKE F
NATHRATH W
SCHMITT M
GRAEFF H
Citation: N. Harbeck et al., PROGNOSTIC-SIGNIFICANCE OF 2 PROLIFERATIO N-ASSOCIATED FACTORS IN NODE-NEGATIVE BREAST-CANCER - S-PHASE AND MIB1 (KI-67), Gynakologisch-geburtshilfliche Rundschau, 35, 1995, pp. 142-147
Authors:
HARBECK N
DETTMAR P
THOMSSEN C
PACHE L
SCHMITT M
JANICKE F
GRAEFF H
Citation: N. Harbeck et al., FLOW CYTOMETRICALLY DETERMINED S-PHASE FRACTION IS A STRONGER PROGNOSTIC FACTOR IN NODE-NEGATIVE BREAST-CANCER THAN IMMUNOHISTOCHEMICALLY DETECTED MIB1 (KI-67), European journal of cancer, 31A, 1995, pp. 664-664
Authors:
DOSE J
JANICKE F
SENEKOWITSCH R
AVRIL N
NATHRATH W
KOLBEN M
GRAEFF H
Citation: J. Dose et al., SIGNET-RING CELL-CARCINOMA OF BOTH OVARIE S OF UNKNOWN ORIGIN IN AN 18-YEAR-OLD PATIENT - ATTEMPT OF AN IMMUNOTHERAPY WITH THE MONOCLONAL-ANTIBODY-B72-3, Tumordiagnostik & Therapie, 16(4), 1995, pp. 153-157
Authors:
REUNING U
WILHELM O
NISHIGUCHI T
GUERRINI L
BLASI F
GRAEFF H
SCHMITT M
Citation: U. Reuning et al., INHIBITION OF NF-KAPPA-B-REL-A EXPRESSION BY ANTISENSE OLIGODEOXYNUCLEOTIDES SUPPRESSES SYNTHESIS OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) BUT NOT ITS INHIBITOR PAI-1, Nucleic acids research, 23(19), 1995, pp. 3887-3893
Authors:
WILHELM O
SCHMITT M
HOHL S
SENEKOWITSCH R
GRAEFF H
Citation: O. Wilhelm et al., ANTISENSE INHIBITION OF UROKINASE REDUCES SPREAD OF HUMAN OVARIAN-CANCER IN MICE, Clinical & experimental metastasis, 13(4), 1995, pp. 296-302
Authors:
MAGDOLEN V
RETTENBERGER P
LOPENS A
OI H
LOTTSPEICH F
KELLERMANN J
CREUTZBURG S
GORETZKI L
WEIDLE UH
WILHELM O
SCHMITT M
GRAEFF H
Citation: V. Magdolen et al., EXPRESSION OF THE HUMAN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTORIN ESCHERICHIA-COLI AND CHINESE-HAMSTER OVARY CELLS - PURIFICATION OFTHE RECOMBINANT PROTEINS AND GENERATION OF POLYCLONAL ANTIBODIES IN CHICKEN, Electrophoresis, 16(5), 1995, pp. 813-816